| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 07/06/2005 | CN1634596A Gene engineering vaccine used for preventing pig cysticercosis and its preparation method |
| 07/06/2005 | CN1634578A Leptospirosis vaccine and its use |
| 07/06/2005 | CN1634319A Chinese traditional medicine compound preparation for treating gynecopathy and preparation method thereof |
| 07/06/2005 | CN1634317A Externally used Chinese traditional medicine preparation for treating bacteroidal, mycotic and trichomonad type genital organs infection |
| 07/06/2005 | CN1634298A Formula of medicine for preventing and curing coccidiosis of chicken |
| 07/06/2005 | CN1209158C Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof |
| 07/05/2005 | US6913892 Method of obtaining compositions comprising Y4 specific compounds |
| 07/05/2005 | US6913889 Methods to screen for antibiotic agents and their use in treatment of opportunistic infections |
| 07/05/2005 | US6913746 The polysaccharides in the complexes form an envelope which protects and carries immunoglobulins allowing their systemic absorption through gastric and mucosal membrane; polysacchride and immunoglobulins are bonded by ionic bonds |
| 06/30/2005 | WO2004035611A3 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 06/30/2005 | US20050143284 Vaccination |
| 06/30/2005 | US20050142069 Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 06/30/2005 | US20050139485 applying a resonance conditioning frequencies, spectral energy pattern to a battery cell reaction system, act to accelerate and catalysis the reaction |
| 06/29/2005 | EP1547615A1 Remedy |
| 06/29/2005 | EP1546726A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 06/29/2005 | EP1545614A2 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 06/29/2005 | EP1545599A1 Immunogenic compositions and diagnostic and therapeutic uses thereof |
| 06/29/2005 | EP1545458A2 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 06/29/2005 | EP1339400B1 N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide deformylase for treating microbial infections |
| 06/29/2005 | EP1315727B1 7-oxo pyridopyrimidines |
| 06/29/2005 | EP1246624B1 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans |
| 06/29/2005 | CN1633444A 6-11 bicyclic ketolide derivatives |
| 06/29/2005 | CN1633416A Nicotinamide derivates useful as p38 inhibitors |
| 06/29/2005 | CN1633309A Method of radio-labelling biomolecules |
| 06/29/2005 | CN1633294A 2, 4, 5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 06/29/2005 | CN1208828C Erase method for non-volatile memory |
| 06/29/2005 | CN1208450C Method for the purification, recovery, and sporulation of cysts and oocysts |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/28/2005 | CA2101924C Specific peptide sequences of hepatic stage p. falciparum bearing epitopes capable of stimulating t lymphocytes |
| 06/23/2005 | WO2004028564A8 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 06/23/2005 | CA2544018A1 Compositions and methods to reduce mutagenesis |
| 06/22/2005 | EP1543325A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 06/22/2005 | CN1630724A Compositions and methods for inhibiting expression of a target gene |
| 06/22/2005 | CN1630712A Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 06/22/2005 | CN1630663A Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 06/22/2005 | CN1630653A Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 06/22/2005 | CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 06/22/2005 | CN1630531A Composition comprising immunogenic microparticles |
| 06/22/2005 | CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/22/2005 | CN1628653A Medicine for trichomonas vaginalis disease |
| 06/21/2005 | US6908937 Heterocyclic fluoroalkenyl thioethers (II) |
| 06/16/2005 | US20050131058 Novel compounds and antimalarials |
| 06/16/2005 | US20050131024 Antiinflammatory agents; autoimmune diseases; anticancer agents |
| 06/16/2005 | US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 06/16/2005 | US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening |
| 06/16/2005 | US20050130125 End of aids for general virology, based on profound science as protein foldings: safe vaccines, universal antimicrobial means, mad cow end |
| 06/16/2005 | US20050129702 Tick chitinase |
| 06/16/2005 | US20050129657 Interferon-alpha induced gene |
| 06/16/2005 | CA2547670A1 Treating infectious diseases using ice inhibitors |
| 06/15/2005 | EP1541170A1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 06/15/2005 | EP1541162A1 Intravaginal washing agent |
| 06/15/2005 | EP1541125A1 Spreadable compositions for topical use, a process of making same and uses thereof |
| 06/15/2005 | EP1539927A1 Probiotic bacterium: lactobacillus fermentum |
| 06/15/2005 | EP1539811A2 Production of bispecific molecules using polyethylene glycol linkers |
| 06/15/2005 | EP1539783A1 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 06/15/2005 | EP1539769A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 06/15/2005 | EP1539719A1 Organic compounds |
| 06/15/2005 | EP1539692A1 Furanone derivatives and methods of making same |
| 06/15/2005 | EP1539683A2 Phenol derivatives and their use as rotamase inhibitors |
| 06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 06/15/2005 | EP1539107A2 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 06/15/2005 | EP1539106A2 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 06/15/2005 | EP1538905A1 High concentration topical insecticide containing pyriproxyfen |
| 06/15/2005 | EP1248836B1 Method for preparing vaccines by using hybrid cells |
| 06/15/2005 | EP1248785B1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 06/15/2005 | CN1627942A Process for isolating srtemisinin from artemisia annua |
| 06/15/2005 | CN1626536A Method of purifying moxidectin through crystallization |
| 06/15/2005 | CN1626530A Spiro and dispiro -1,2,4-trioxalane antimalarials |
| 06/15/2005 | CN1206219C N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/15/2005 | CN1205964C Medicament for curing colpitismycotica and trichomonal vaginitis and its preparation method |
| 06/15/2005 | CN1205929C Local administration preparation |
| 06/15/2005 | CN1205927C Water soluble trioxanes as potent and safe anti-malarial agents |
| 06/15/2005 | CN1205926C Agents for combating neospora spec |
| 06/15/2005 | CN1205921C Long acting injectable formulations contg. hydrogenated castor oil |
| 06/14/2005 | US6906184 Catalytic hydrogenation in solvent; oxidation |
| 06/14/2005 | US6906076 Inactivating a nuclear localization signal of a protein by contacting the protein with a compound that binds reversibly; parasiticides; viricides |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/14/2005 | US6905679 Gastrointestinal disorders |
| 06/09/2005 | WO2005012276A3 Intermediate products of the synthesis of fluorized inhibitors of aspartic proteases |
| 06/09/2005 | US20050124578 Aqueous compositions containing metronidazole |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123576 Mupirocin compositions for topical use, an improved process of making same and methods of using same |
| 06/09/2005 | US20050123575 Heating, cooling, reheating and recooling a mixture containing hard fat while stirring; cosmetics, cosmeceutical, pharmaceutical; second temperature is lower than the congelation temperature of the mixture; hard fat is a mixture of triester of glycerin with caprylic, capric and stearic acids |
| 06/09/2005 | US20050123557 AntiI-protozoal vaccine |
| 06/09/2005 | US20050123523 Immunostimulatory nucleic acid molecules |
| 06/09/2005 | US20050123511 vector comprising heterologous nucleic acid molecules that code antigenic polypeptides |
| 06/08/2005 | EP1537870A2 Methods and compositions for treating cancer |
| 06/08/2005 | EP1537857A1 Mupirocin compositions for topical use, a process of making same and uses thereof |
| 06/08/2005 | EP1537226A1 Method for reproducing pleuromutilins |
| 06/08/2005 | EP1537129A1 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 06/08/2005 | EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 06/08/2005 | EP1102775B1 Novel phospholipids with unsaturated alkyl and acyl chains |
| 06/08/2005 | CN1625567A Novel monoclonal antibody and nematode larval antigens |
| 06/08/2005 | CN1625396A Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases |
| 06/08/2005 | CN1205220C Novel cyclosporins |
| 06/07/2005 | US6903080 Disease treatment with novel phospholipid derivatives |
| 06/07/2005 | US6903076 Antihelminthic anthraquinones and method of use thereof |
| 06/07/2005 | CA2332686C Novel 13 and 14-membered antibacterial and prokinetic macrolides and their intermediates |
| 06/02/2005 | US20050119232 10 alpha -(sulfamino)dihydroartemisinin and Bis[(10 alpha -dihydroartemisinyl)]sulfamide; parasiticide; malaria, neosporosis and coccidiosis; Plasmodium falciparum, Neospora caninum and Eimeria tenella; improved stability, bioavailability, neurotoxicity |
| 06/02/2005 | US20050118717 delivering to microtubules a microtubule binding substance, such as taxol, that is coupled to a herpes simplex virus 1 VP22 protein; may be used pharmaceutically to retard or arrest cell division of cells such as neoplastic cells or protozoal parasite cells in vitro or in vivo. |